Prise en charge des événements indésirables chez les patients sous traitement par immunoglobulines : recommandations pour la pratique clinique

摘要: Both intravenous and subcutaneous immunoglobulins are therapeutic modalities approved in various conditions, including primary secondary immune deficiencies autoimmune disorders. To date, have more often been considered as a safe medication, with minor adverse effects such hypertension, fever chills, nausea, myalgia or headache. However, the wider use of treatment diseases, severe side also reported to occur immunoglobulin-treated patients, especially anaphylaxis, aseptic meningitis, acute renal impairment, thrombotic events well haematological manifestations. This paper reviews all potential related immunoglobulin therapy establishes comprehensive guideline for management these events.